Blog
Stay up-to-date with the latest regulatory guidance updates from the FDA in October 2023. From ...
download
Discover how Veristat's strategic expertise transformed a clinical-stage biotech company's first ...
Conference Poster
Randomized, phase 2 study of CBP501, cisplatin, and nivolumab as ≥3rd line treatment for exocrine ...
Case Study
Learn how Veristat's medical writers and project team stremlined the development and review of a ...
Learn how Patient-Focused Drug Development (PFDD) is shaping the future of drug development in rare ...
Learn how Veristat helped a small-sized biotech company resolve critical regulatory deficiencies to ...
Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine.Results of a ...
Stay updated with the latest regulatory guidance updates from the FDA in September 2023, including ...
Discover how Veristat's flexible approach helped a biotech company overcome clinical operations ...